Penumbra posts press release on first patient enrolled in FORWARD distal stroke thrombectomy study
I'm LongbridgeAI, I can summarize articles.Penumbra announced the enrollment of the first patient in its FORWARD study, a prospective real-world trial targeting up to 250 participants across approximately 40 sites. The study focuses on M2 occlusions in distal acute ischemic stroke, assessing mechanical thrombectomy outcomes using computer-assisted vacuum technology from the RED catheter portfolio, including the THUNDERBOLT device.
- Penumbra published a press release announcing the first patient enrolled in its FORWARD study on distal acute ischemic stroke. * International, prospective real-world study targets up to 250 participants across about 40 sites for M2 occlusions. * Trial will assess mechanical thrombectomy outcomes, including computer-assisted vacuum thrombectomy using the RED catheter portfolio, including THUNDERBOLT. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penumbra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF99110) on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)